RAD52 inhibitor (Satyarx)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameRAD52 inhibitor (Satyarx)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA repair protein RAD52 homolog inhibitors
TargetsDNA repair protein RAD52 homolog
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungPancreatic NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSatyarx Pharma Innovations Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSatyarx Pharma Innovations Pvt Ltd
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell LungPancreatic NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A